Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc. (MDGL) — Form 144: Proposed sale of shares
About this filing
Madrigal Pharmaceuticals Inc. (MDGL) filed Form 144 (proposed sale of shares) with the SEC on Sep 28, 2026. Form 144 is notice that an insider or affiliate plans to sell shares.
Key facts
- Seller
- PAUL FRIEDMAN
- Relationship
- Director
- Shares to sell
- 50,000
- Market value
- $25,828,000.00
- Approximate sale date
- Sep 28, 2026
- Broker
- Morgan Stanley Smith Barney LLC Executive Financial Services
- Acquired
- Sep 28, 2026 · Exercise of Stock Options
Rule 10b5-1 plan · adopted Aug 28, 2026
Remarks
- The reported sales occur automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 8/28/2026.
More MDGL filings
- SC 13D/A
Filed Nov 6, 2026
- 4
Filed Nov 6, 2026
- 4
Filed Nov 6, 2026
- 144
Filed Nov 6, 2026
- 10-Q
Filed Nov 3, 2026
- 8-K
Filed Nov 3, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.